Team members involved:

Team members involved:

Datix is the UK’s leading provider of patient safety and risk management software to the healthcare industry. Its products are used widely within both public and private healthcare organisations around the world, with over 80 million people protected by its software.

  • Investment: April 2008
  • Sector: Healthcare and Technology
  • Business: Healthcare software
  • Growth Strategy: Product development and international expansion

Why we invested

Risk management systems are a regulatory requirement for healthcare institutions, and the increasing levels of both regulation and litigation are driving growth in domestic and overseas markets. This was an opportunity to help the leading company in its field capitalise on these growth opportunities, by investing in new product innovation and expansion into overseas markets.

The result

During the five years of our ownership, Datix significantly expanded its operations into new vertical markets and geographic regions. This included the roll-out of its software by the US Department of Defense in its Military Health System, and by other major providers of healthcare services in the US, Canada, Europe, Australia and the Middle East.  In July 2013, the company was sold to a management buy-out funded by a consortium of private investors.

Website: Read more about our Technology strategy

Bowmark was very supportive and really bought into our plans, providing help and assistance with our strategy, as well as some valuable ideas for new direction.

Jonathan Hazan, Chief Executive
Back to portfolio